Prenetics Global Ltd - Class A

NAS:PRE (Hong Kong)   Class A
$ 3.19 +0.04 (+1.27%) 11:09 PM EST
At Loss
P/B:
0.17
Market Cap:
$ 38.94M
Enterprise V:
$ -25.26M
Volume:
71.12K
Avg Vol (2M):
112.19K
Volume:
71.12K
At Loss
Avg Vol (2M):
112.19K

Business Description

Prenetics Global Ltd
NAICS : 621512 SIC : 8734
ISIN : BMG686031698

Share Class Description:

PRE: Class A
Description
Prenetics Global Ltd is a diagnostic and genetic testing company. It is a genomics and precision oncology company that has devised a method to integrate early detection for cancer, targeted therapy and direct-to-consumer genetic testing services into one comprehensive platform. It operates in two segments. The prevention segment includes the design & sale of genetics testing (including update services) & stool-based DNA tests for early colorectal cancer screening. The diagnostic segment includes the sale of COVID-19 testing services & products and precision oncology services. The majority of revenue is from the diagnostics segment. Geographically, it operates in Hong Kong and the United Kingdom, out of which the majority is from Hong Kong.
Name Current Vs Industry Vs History
Cash-To-Debt 13.09
Equity-to-Asset 0.81
Debt-to-Equity 0.02
Debt-to-EBITDA -0.7
Piotroski F-Score 7/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.7
Distress
Grey
Safe
Beneish M-Score -2.8
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year Revenue Growth Rate 251.9
3-Year EBITDA Growth Rate -139.7
3-Year EPS without NRI Growth Rate -82.9

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 24.66
9-Day RSI 29.97
14-Day RSI 32.91
6-1 Month Momentum % -32.26
12-1 Month Momentum % -63.74

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.61
Quick Ratio 2.53
Cash Ratio 1.71
Days Inventory 11.09
Days Sales Outstanding 29.71
Days Payable 15.09

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -7.3
Shareholder Yield % 16.94

Financials (Next Earnings Date:2024-06-05 Est.)

PRE's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Prenetics Global Ltd Operating Data

PRE's Complete Operating Data
No operating data available for Prenetics Global Ltd.

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:PRE

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Prenetics Global Ltd Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 291.437
EPS (TTM) ($) -4.2
Beta 0
Volatility % 65.85
14-Day RSI 32.91
14-Day ATR ($) 0.333437
20-Day SMA ($) 3.77837
12-1 Month Momentum % -63.74
52-Week Range ($) 3.14 - 15.899999
Shares Outstanding (Mil) 12.21

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 7
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Prenetics Global Ltd Filings

Filing Date Document Date Form
No Filing Data

Prenetics Global Ltd Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Prenetics Global Ltd Frequently Asked Questions

What is Prenetics Global Ltd(PRE)'s stock price today?
The current price of PRE is $3.19. The 52 week high of PRE is $15.90 and 52 week low is $3.14.
When is next earnings date of Prenetics Global Ltd(PRE)?
The next earnings date of Prenetics Global Ltd(PRE) is 2024-06-05 Est..
Does Prenetics Global Ltd(PRE) pay dividends? If so, how much?
Prenetics Global Ltd(PRE) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1